Balancing the Risks and Benefits of Benzodiazepines

Matthew E Hirschtritt¹, Mark Olfson^{2

3}, Kurt Kroenke^{4

5}

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
² Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York, New York.
³ Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York.
⁴ Department of Medicine, Indiana University School of Medicine, Indianapolis.
⁵ Regenstrief Institute Inc, Indianapolis, Indiana.

Free article

Matthew E Hirschtritt et al. JAMA. 2021.

Free article

. 2021 Jan 26;325(4):347-348.

doi: 10.1001/jama.2020.22106.

Matthew E Hirschtritt¹, Mark Olfson^{2

3}, Kurt Kroenke^{4

5}

¹ Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
² Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York, New York.
³ Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York.
⁴ Department of Medicine, Indiana University School of Medicine, Indianapolis.
⁵ Regenstrief Institute Inc, Indianapolis, Indiana.

No abstract available

Comment in

Risks and Benefits of Benzodiazepines.
Shrestha U, Karnik R, Joshi N. Shrestha U, et al. JAMA. 2021 Jun 1;325(21):2209. doi: 10.1001/jama.2021.4516. JAMA. 2021. PMID: 34061150 No abstract available.
Risks and Benefits of Benzodiazepines.
Horowitz MA, Wright JM, Taylor D. Horowitz MA, et al. JAMA. 2021 Jun 1;325(21):2208. doi: 10.1001/jama.2021.4513. JAMA. 2021. PMID: 34061151 No abstract available.